Global Parenteral Nutrition Medicament Market Research Report 2023

Publisher Name :
Date: 03-Feb-2023
No. of pages: 106
Inquire Before Buying

Highlights

The global Parenteral Nutrition Medicament market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.

North American market for Parenteral Nutrition Medicament is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

Asia-Pacific market for Parenteral Nutrition Medicament is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The key global manufacturers of Parenteral Nutrition Medicament include Baxter, B. Braun, Fresenius Kabi, Kelun Pharma, Otsuka Pharmaceutical, JW Pharmaceutical, Pfizer, Teva Pharmaceutical and Haisco Pharmaceutical Group, etc. in 2022, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Parenteral Nutrition Medicament, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Parenteral Nutrition Medicament.

The Parenteral Nutrition Medicament market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Parenteral Nutrition Medicament market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Parenteral Nutrition Medicament manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.

By Company

- Baxter

- B. Braun

- Fresenius Kabi

- Kelun Pharma

- Otsuka Pharmaceutical

- JW Pharmaceutical

- Pfizer

- Teva Pharmaceutical

- Haisco Pharmaceutical Group

- King York

- Cisen

- Lummy

- Grand Life Sciences

- Medisan

- BBCA Pharmaceutical

- Biokin Pharmaceutical

- Xi'an Libang Pharmaceutical

- Lionco Pharmaceutical

- China Meheco Kangli

Segment by Type

- Heat

- Amino Acid

- Vitamins

Segment by Application

- max. 100ml

- 250ml

- 500ml

- min. 1L

Consumption by Region

- North America

- United States

- Canada

- Europe

- Germany

- France

- U.K.

- Italy

- Russia

- Asia-Pacific

- China

- Japan

- South Korea

- India

- Australia

- China Taiwan

- Indonesia

- Thailand

- Malaysia

- Latin America

- Mexico

- Brazil

- Argentina

- Middle East & Africa

- Turkey

- Saudi Arabia

- UAE

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Detailed analysis of Parenteral Nutrition Medicament manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Sales, revenue of Parenteral Nutrition Medicament in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 9: The main points and conclusions of the report.

Global Parenteral Nutrition Medicament Market Research Report 2023

Table of Contents
1 Parenteral Nutrition Medicament Market Overview
1.1 Product Overview and Scope of Parenteral Nutrition Medicament
1.2 Parenteral Nutrition Medicament Segment by Type
1.2.1 Global Parenteral Nutrition Medicament Market Value Comparison by Type (2023-2029)
1.2.2 Heat
1.2.3 Amino Acid
1.2.4 Vitamins
1.3 Parenteral Nutrition Medicament Segment by Application
1.3.1 Global Parenteral Nutrition Medicament Market Value by Application: (2023-2029)
1.3.2 max. 100ml
1.3.3 250ml
1.3.4 500ml
1.3.5 min. 1L
1.4 Global Parenteral Nutrition Medicament Market Size Estimates and Forecasts
1.4.1 Global Parenteral Nutrition Medicament Revenue 2018-2029
1.4.2 Global Parenteral Nutrition Medicament Sales 2018-2029
1.4.3 Global Parenteral Nutrition Medicament Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Parenteral Nutrition Medicament Market Competition by Manufacturers
2.1 Global Parenteral Nutrition Medicament Sales Market Share by Manufacturers (2018-2023)
2.2 Global Parenteral Nutrition Medicament Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Parenteral Nutrition Medicament Average Price by Manufacturers (2018-2023)
2.4 Global Parenteral Nutrition Medicament Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Parenteral Nutrition Medicament, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Parenteral Nutrition Medicament, Product Type & Application
2.7 Parenteral Nutrition Medicament Market Competitive Situation and Trends
2.7.1 Parenteral Nutrition Medicament Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Parenteral Nutrition Medicament Players Market Share by Revenue
2.7.3 Global Parenteral Nutrition Medicament Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Parenteral Nutrition Medicament Retrospective Market Scenario by Region
3.1 Global Parenteral Nutrition Medicament Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Parenteral Nutrition Medicament Global Parenteral Nutrition Medicament Sales by Region: 2018-2029
3.2.1 Global Parenteral Nutrition Medicament Sales by Region: 2018-2023
3.2.2 Global Parenteral Nutrition Medicament Sales by Region: 2024-2029
3.3 Global Parenteral Nutrition Medicament Global Parenteral Nutrition Medicament Revenue by Region: 2018-2029
3.3.1 Global Parenteral Nutrition Medicament Revenue by Region: 2018-2023
3.3.2 Global Parenteral Nutrition Medicament Revenue by Region: 2024-2029
3.4 North America Parenteral Nutrition Medicament Market Facts & Figures by Country
3.4.1 North America Parenteral Nutrition Medicament Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Parenteral Nutrition Medicament Sales by Country (2018-2029)
3.4.3 North America Parenteral Nutrition Medicament Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Parenteral Nutrition Medicament Market Facts & Figures by Country
3.5.1 Europe Parenteral Nutrition Medicament Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Parenteral Nutrition Medicament Sales by Country (2018-2029)
3.5.3 Europe Parenteral Nutrition Medicament Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Parenteral Nutrition Medicament Market Facts & Figures by Country
3.6.1 Asia Pacific Parenteral Nutrition Medicament Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Parenteral Nutrition Medicament Sales by Country (2018-2029)
3.6.3 Asia Pacific Parenteral Nutrition Medicament Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Parenteral Nutrition Medicament Market Facts & Figures by Country
3.7.1 Latin America Parenteral Nutrition Medicament Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Parenteral Nutrition Medicament Sales by Country (2018-2029)
3.7.3 Latin America Parenteral Nutrition Medicament Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Parenteral Nutrition Medicament Market Facts & Figures by Country
3.8.1 Middle East and Africa Parenteral Nutrition Medicament Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Parenteral Nutrition Medicament Sales by Country (2018-2029)
3.8.3 Middle East and Africa Parenteral Nutrition Medicament Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Parenteral Nutrition Medicament Sales by Type (2018-2029)
4.1.1 Global Parenteral Nutrition Medicament Sales by Type (2018-2023)
4.1.2 Global Parenteral Nutrition Medicament Sales by Type (2024-2029)
4.1.3 Global Parenteral Nutrition Medicament Sales Market Share by Type (2018-2029)
4.2 Global Parenteral Nutrition Medicament Revenue by Type (2018-2029)
4.2.1 Global Parenteral Nutrition Medicament Revenue by Type (2018-2023)
4.2.2 Global Parenteral Nutrition Medicament Revenue by Type (2024-2029)
4.2.3 Global Parenteral Nutrition Medicament Revenue Market Share by Type (2018-2029)
4.3 Global Parenteral Nutrition Medicament Price by Type (2018-2029)
5 Segment by Application
5.1 Global Parenteral Nutrition Medicament Sales by Application (2018-2029)
5.1.1 Global Parenteral Nutrition Medicament Sales by Application (2018-2023)
5.1.2 Global Parenteral Nutrition Medicament Sales by Application (2024-2029)
5.1.3 Global Parenteral Nutrition Medicament Sales Market Share by Application (2018-2029)
5.2 Global Parenteral Nutrition Medicament Revenue by Application (2018-2029)
5.2.1 Global Parenteral Nutrition Medicament Revenue by Application (2018-2023)
5.2.2 Global Parenteral Nutrition Medicament Revenue by Application (2024-2029)
5.2.3 Global Parenteral Nutrition Medicament Revenue Market Share by Application (2018-2029)
5.3 Global Parenteral Nutrition Medicament Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Baxter
6.1.1 Baxter Corporation Information
6.1.2 Baxter Description and Business Overview
6.1.3 Baxter Parenteral Nutrition Medicament Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Baxter Parenteral Nutrition Medicament Product Portfolio
6.1.5 Baxter Recent Developments/Updates
6.2 B. Braun
6.2.1 B. Braun Corporation Information
6.2.2 B. Braun Description and Business Overview
6.2.3 B. Braun Parenteral Nutrition Medicament Sales, Revenue and Gross Margin (2018-2023)
6.2.4 B. Braun Parenteral Nutrition Medicament Product Portfolio
6.2.5 B. Braun Recent Developments/Updates
6.3 Fresenius Kabi
6.3.1 Fresenius Kabi Corporation Information
6.3.2 Fresenius Kabi Description and Business Overview
6.3.3 Fresenius Kabi Parenteral Nutrition Medicament Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Fresenius Kabi Parenteral Nutrition Medicament Product Portfolio
6.3.5 Fresenius Kabi Recent Developments/Updates
6.4 Kelun Pharma
6.4.1 Kelun Pharma Corporation Information
6.4.2 Kelun Pharma Description and Business Overview
6.4.3 Kelun Pharma Parenteral Nutrition Medicament Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Kelun Pharma Parenteral Nutrition Medicament Product Portfolio
6.4.5 Kelun Pharma Recent Developments/Updates
6.5 Otsuka Pharmaceutical
6.5.1 Otsuka Pharmaceutical Corporation Information
6.5.2 Otsuka Pharmaceutical Description and Business Overview
6.5.3 Otsuka Pharmaceutical Parenteral Nutrition Medicament Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Otsuka Pharmaceutical Parenteral Nutrition Medicament Product Portfolio
6.5.5 Otsuka Pharmaceutical Recent Developments/Updates
6.6 JW Pharmaceutical
6.6.1 JW Pharmaceutical Corporation Information
6.6.2 JW Pharmaceutical Description and Business Overview
6.6.3 JW Pharmaceutical Parenteral Nutrition Medicament Sales, Revenue and Gross Margin (2018-2023)
6.6.4 JW Pharmaceutical Parenteral Nutrition Medicament Product Portfolio
6.6.5 JW Pharmaceutical Recent Developments/Updates
6.7 Pfizer
6.6.1 Pfizer Corporation Information
6.6.2 Pfizer Description and Business Overview
6.6.3 Pfizer Parenteral Nutrition Medicament Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Pfizer Parenteral Nutrition Medicament Product Portfolio
6.7.5 Pfizer Recent Developments/Updates
6.8 Teva Pharmaceutical
6.8.1 Teva Pharmaceutical Corporation Information
6.8.2 Teva Pharmaceutical Description and Business Overview
6.8.3 Teva Pharmaceutical Parenteral Nutrition Medicament Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Teva Pharmaceutical Parenteral Nutrition Medicament Product Portfolio
6.8.5 Teva Pharmaceutical Recent Developments/Updates
6.9 Haisco Pharmaceutical Group
6.9.1 Haisco Pharmaceutical Group Corporation Information
6.9.2 Haisco Pharmaceutical Group Description and Business Overview
6.9.3 Haisco Pharmaceutical Group Parenteral Nutrition Medicament Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Haisco Pharmaceutical Group Parenteral Nutrition Medicament Product Portfolio
6.9.5 Haisco Pharmaceutical Group Recent Developments/Updates
6.10 King York
6.10.1 King York Corporation Information
6.10.2 King York Description and Business Overview
6.10.3 King York Parenteral Nutrition Medicament Sales, Revenue and Gross Margin (2018-2023)
6.10.4 King York Parenteral Nutrition Medicament Product Portfolio
6.10.5 King York Recent Developments/Updates
6.11 Cisen
6.11.1 Cisen Corporation Information
6.11.2 Cisen Parenteral Nutrition Medicament Description and Business Overview
6.11.3 Cisen Parenteral Nutrition Medicament Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Cisen Parenteral Nutrition Medicament Product Portfolio
6.11.5 Cisen Recent Developments/Updates
6.12 Lummy
6.12.1 Lummy Corporation Information
6.12.2 Lummy Parenteral Nutrition Medicament Description and Business Overview
6.12.3 Lummy Parenteral Nutrition Medicament Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Lummy Parenteral Nutrition Medicament Product Portfolio
6.12.5 Lummy Recent Developments/Updates
6.13 Grand Life Sciences
6.13.1 Grand Life Sciences Corporation Information
6.13.2 Grand Life Sciences Parenteral Nutrition Medicament Description and Business Overview
6.13.3 Grand Life Sciences Parenteral Nutrition Medicament Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Grand Life Sciences Parenteral Nutrition Medicament Product Portfolio
6.13.5 Grand Life Sciences Recent Developments/Updates
6.14 Medisan
6.14.1 Medisan Corporation Information
6.14.2 Medisan Parenteral Nutrition Medicament Description and Business Overview
6.14.3 Medisan Parenteral Nutrition Medicament Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Medisan Parenteral Nutrition Medicament Product Portfolio
6.14.5 Medisan Recent Developments/Updates
6.15 BBCA Pharmaceutical
6.15.1 BBCA Pharmaceutical Corporation Information
6.15.2 BBCA Pharmaceutical Parenteral Nutrition Medicament Description and Business Overview
6.15.3 BBCA Pharmaceutical Parenteral Nutrition Medicament Sales, Revenue and Gross Margin (2018-2023)
6.15.4 BBCA Pharmaceutical Parenteral Nutrition Medicament Product Portfolio
6.15.5 BBCA Pharmaceutical Recent Developments/Updates
6.16 Biokin Pharmaceutical
6.16.1 Biokin Pharmaceutical Corporation Information
6.16.2 Biokin Pharmaceutical Parenteral Nutrition Medicament Description and Business Overview
6.16.3 Biokin Pharmaceutical Parenteral Nutrition Medicament Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Biokin Pharmaceutical Parenteral Nutrition Medicament Product Portfolio
6.16.5 Biokin Pharmaceutical Recent Developments/Updates
6.17 Xi'an Libang Pharmaceutical
6.17.1 Xi'an Libang Pharmaceutical Corporation Information
6.17.2 Xi'an Libang Pharmaceutical Parenteral Nutrition Medicament Description and Business Overview
6.17.3 Xi'an Libang Pharmaceutical Parenteral Nutrition Medicament Sales, Revenue and Gross Margin (2018-2023)
6.17.4 Xi'an Libang Pharmaceutical Parenteral Nutrition Medicament Product Portfolio
6.17.5 Xi'an Libang Pharmaceutical Recent Developments/Updates
6.18 Lionco Pharmaceutical
6.18.1 Lionco Pharmaceutical Corporation Information
6.18.2 Lionco Pharmaceutical Parenteral Nutrition Medicament Description and Business Overview
6.18.3 Lionco Pharmaceutical Parenteral Nutrition Medicament Sales, Revenue and Gross Margin (2018-2023)
6.18.4 Lionco Pharmaceutical Parenteral Nutrition Medicament Product Portfolio
6.18.5 Lionco Pharmaceutical Recent Developments/Updates
6.19 China Meheco Kangli
6.19.1 China Meheco Kangli Corporation Information
6.19.2 China Meheco Kangli Parenteral Nutrition Medicament Description and Business Overview
6.19.3 China Meheco Kangli Parenteral Nutrition Medicament Sales, Revenue and Gross Margin (2018-2023)
6.19.4 China Meheco Kangli Parenteral Nutrition Medicament Product Portfolio
6.19.5 China Meheco Kangli Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Parenteral Nutrition Medicament Industry Chain Analysis
7.2 Parenteral Nutrition Medicament Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Parenteral Nutrition Medicament Production Mode & Process
7.4 Parenteral Nutrition Medicament Sales and Marketing
7.4.1 Parenteral Nutrition Medicament Sales Channels
7.4.2 Parenteral Nutrition Medicament Distributors
7.5 Parenteral Nutrition Medicament Customers
8 Parenteral Nutrition Medicament Market Dynamics
8.1 Parenteral Nutrition Medicament Industry Trends
8.2 Parenteral Nutrition Medicament Market Drivers
8.3 Parenteral Nutrition Medicament Market Challenges
8.4 Parenteral Nutrition Medicament Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Parenteral Nutrition Medicament Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Parenteral Nutrition Medicament Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Parenteral Nutrition Medicament Market Competitive Situation by Manufacturers in 2022
Table 4. Global Parenteral Nutrition Medicament Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Parenteral Nutrition Medicament Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Parenteral Nutrition Medicament Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Parenteral Nutrition Medicament Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Parenteral Nutrition Medicament Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Parenteral Nutrition Medicament, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Parenteral Nutrition Medicament, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Parenteral Nutrition Medicament, Product Type & Application
Table 12. Global Key Manufacturers of Parenteral Nutrition Medicament, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Parenteral Nutrition Medicament by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Parenteral Nutrition Medicament as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Parenteral Nutrition Medicament Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Parenteral Nutrition Medicament Sales by Region (2018-2023) & (K Units)
Table 18. Global Parenteral Nutrition Medicament Sales Market Share by Region (2018-2023)
Table 19. Global Parenteral Nutrition Medicament Sales by Region (2024-2029) & (K Units)
Table 20. Global Parenteral Nutrition Medicament Sales Market Share by Region (2024-2029)
Table 21. Global Parenteral Nutrition Medicament Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Parenteral Nutrition Medicament Revenue Market Share by Region (2018-2023)
Table 23. Global Parenteral Nutrition Medicament Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Parenteral Nutrition Medicament Revenue Market Share by Region (2024-2029)
Table 25. North America Parenteral Nutrition Medicament Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Parenteral Nutrition Medicament Sales by Country (2018-2023) & (K Units)
Table 27. North America Parenteral Nutrition Medicament Sales by Country (2024-2029) & (K Units)
Table 28. North America Parenteral Nutrition Medicament Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Parenteral Nutrition Medicament Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Parenteral Nutrition Medicament Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Parenteral Nutrition Medicament Sales by Country (2018-2023) & (K Units)
Table 32. Europe Parenteral Nutrition Medicament Sales by Country (2024-2029) & (K Units)
Table 33. Europe Parenteral Nutrition Medicament Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Parenteral Nutrition Medicament Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Parenteral Nutrition Medicament Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Parenteral Nutrition Medicament Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Parenteral Nutrition Medicament Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Parenteral Nutrition Medicament Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Parenteral Nutrition Medicament Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Parenteral Nutrition Medicament Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Parenteral Nutrition Medicament Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Parenteral Nutrition Medicament Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Parenteral Nutrition Medicament Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Parenteral Nutrition Medicament Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Parenteral Nutrition Medicament Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Parenteral Nutrition Medicament Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Parenteral Nutrition Medicament Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Parenteral Nutrition Medicament Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Parenteral Nutrition Medicament Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Parenteral Nutrition Medicament Sales (K Units) by Type (2018-2023)
Table 51. Global Parenteral Nutrition Medicament Sales (K Units) by Type (2024-2029)
Table 52. Global Parenteral Nutrition Medicament Sales Market Share by Type (2018-2023)
Table 53. Global Parenteral Nutrition Medicament Sales Market Share by Type (2024-2029)
Table 54. Global Parenteral Nutrition Medicament Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Parenteral Nutrition Medicament Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Parenteral Nutrition Medicament Revenue Market Share by Type (2018-2023)
Table 57. Global Parenteral Nutrition Medicament Revenue Market Share by Type (2024-2029)
Table 58. Global Parenteral Nutrition Medicament Price (US$/Unit) by Type (2018-2023)
Table 59. Global Parenteral Nutrition Medicament Price (US$/Unit) by Type (2024-2029)
Table 60. Global Parenteral Nutrition Medicament Sales (K Units) by Application (2018-2023)
Table 61. Global Parenteral Nutrition Medicament Sales (K Units) by Application (2024-2029)
Table 62. Global Parenteral Nutrition Medicament Sales Market Share by Application (2018-2023)
Table 63. Global Parenteral Nutrition Medicament Sales Market Share by Application (2024-2029)
Table 64. Global Parenteral Nutrition Medicament Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Parenteral Nutrition Medicament Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Parenteral Nutrition Medicament Revenue Market Share by Application (2018-2023)
Table 67. Global Parenteral Nutrition Medicament Revenue Market Share by Application (2024-2029)
Table 68. Global Parenteral Nutrition Medicament Price (US$/Unit) by Application (2018-2023)
Table 69. Global Parenteral Nutrition Medicament Price (US$/Unit) by Application (2024-2029)
Table 70. Baxter Corporation Information
Table 71. Baxter Description and Business Overview
Table 72. Baxter Parenteral Nutrition Medicament Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. Baxter Parenteral Nutrition Medicament Product
Table 74. Baxter Recent Developments/Updates
Table 75. B. Braun Corporation Information
Table 76. B. Braun Description and Business Overview
Table 77. B. Braun Parenteral Nutrition Medicament Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. B. Braun Parenteral Nutrition Medicament Product
Table 79. B. Braun Recent Developments/Updates
Table 80. Fresenius Kabi Corporation Information
Table 81. Fresenius Kabi Description and Business Overview
Table 82. Fresenius Kabi Parenteral Nutrition Medicament Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Fresenius Kabi Parenteral Nutrition Medicament Product
Table 84. Fresenius Kabi Recent Developments/Updates
Table 85. Kelun Pharma Corporation Information
Table 86. Kelun Pharma Description and Business Overview
Table 87. Kelun Pharma Parenteral Nutrition Medicament Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Kelun Pharma Parenteral Nutrition Medicament Product
Table 89. Kelun Pharma Recent Developments/Updates
Table 90. Otsuka Pharmaceutical Corporation Information
Table 91. Otsuka Pharmaceutical Description and Business Overview
Table 92. Otsuka Pharmaceutical Parenteral Nutrition Medicament Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Otsuka Pharmaceutical Parenteral Nutrition Medicament Product
Table 94. Otsuka Pharmaceutical Recent Developments/Updates
Table 95. JW Pharmaceutical Corporation Information
Table 96. JW Pharmaceutical Description and Business Overview
Table 97. JW Pharmaceutical Parenteral Nutrition Medicament Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. JW Pharmaceutical Parenteral Nutrition Medicament Product
Table 99. JW Pharmaceutical Recent Developments/Updates
Table 100. Pfizer Corporation Information
Table 101. Pfizer Description and Business Overview
Table 102. Pfizer Parenteral Nutrition Medicament Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Pfizer Parenteral Nutrition Medicament Product
Table 104. Pfizer Recent Developments/Updates
Table 105. Teva Pharmaceutical Corporation Information
Table 106. Teva Pharmaceutical Description and Business Overview
Table 107. Teva Pharmaceutical Parenteral Nutrition Medicament Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Teva Pharmaceutical Parenteral Nutrition Medicament Product
Table 109. Teva Pharmaceutical Recent Developments/Updates
Table 110. Haisco Pharmaceutical Group Corporation Information
Table 111. Haisco Pharmaceutical Group Description and Business Overview
Table 112. Haisco Pharmaceutical Group Parenteral Nutrition Medicament Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Haisco Pharmaceutical Group Parenteral Nutrition Medicament Product
Table 114. Haisco Pharmaceutical Group Recent Developments/Updates
Table 115. King York Corporation Information
Table 116. King York Description and Business Overview
Table 117. King York Parenteral Nutrition Medicament Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. King York Parenteral Nutrition Medicament Product
Table 119. King York Recent Developments/Updates
Table 120. Cisen Corporation Information
Table 121. Cisen Description and Business Overview
Table 122. Cisen Parenteral Nutrition Medicament Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. Cisen Parenteral Nutrition Medicament Product
Table 124. Cisen Recent Developments/Updates
Table 125. Lummy Corporation Information
Table 126. Lummy Description and Business Overview
Table 127. Lummy Parenteral Nutrition Medicament Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. Lummy Parenteral Nutrition Medicament Product
Table 129. Lummy Recent Developments/Updates
Table 130. Grand Life Sciences Corporation Information
Table 131. Grand Life Sciences Description and Business Overview
Table 132. Grand Life Sciences Parenteral Nutrition Medicament Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 133. Grand Life Sciences Parenteral Nutrition Medicament Product
Table 134. Grand Life Sciences Recent Developments/Updates
Table 135. Medisan Corporation Information
Table 136. Medisan Description and Business Overview
Table 137. Medisan Parenteral Nutrition Medicament Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 138. Medisan Parenteral Nutrition Medicament Product
Table 139. Medisan Recent Developments/Updates
Table 140. BBCA Pharmaceutical Corporation Information
Table 141. BBCA Pharmaceutical Description and Business Overview
Table 142. BBCA Pharmaceutical Parenteral Nutrition Medicament Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 143. BBCA Pharmaceutical Parenteral Nutrition Medicament Product
Table 144. BBCA Pharmaceutical Recent Developments/Updates
Table 145. Biokin Pharmaceutical Corporation Information
Table 146. Biokin Pharmaceutical Description and Business Overview
Table 147. Biokin Pharmaceutical Parenteral Nutrition Medicament Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 148. Biokin Pharmaceutical Parenteral Nutrition Medicament Product
Table 149. Biokin Pharmaceutical Recent Developments/Updates
Table 150. Xi'an Libang Pharmaceutical Corporation Information
Table 151. Xi'an Libang Pharmaceutical Description and Business Overview
Table 152. Xi'an Libang Pharmaceutical Parenteral Nutrition Medicament Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 153. Xi'an Libang Pharmaceutical Parenteral Nutrition Medicament Product
Table 154. Xi'an Libang Pharmaceutical Recent Developments/Updates
Table 155. Lionco Pharmaceutical Corporation Information
Table 156. Lionco Pharmaceutical Description and Business Overview
Table 157. Lionco Pharmaceutical Parenteral Nutrition Medicament Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 158. Lionco Pharmaceutical Parenteral Nutrition Medicament Product
Table 159. Lionco Pharmaceutical Recent Developments/Updates
Table 160. China Meheco Kangli Corporation Information
Table 161. China Meheco Kangli Description and Business Overview
Table 162. China Meheco Kangli Parenteral Nutrition Medicament Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 163. China Meheco Kangli Parenteral Nutrition Medicament Product
Table 164. China Meheco Kangli Recent Developments/Updates
Table 165. Key Raw Materials Lists
Table 166. Raw Materials Key Suppliers Lists
Table 167. Parenteral Nutrition Medicament Distributors List
Table 168. Parenteral Nutrition Medicament Customers List
Table 169. Parenteral Nutrition Medicament Market Trends
Table 170. Parenteral Nutrition Medicament Market Drivers
Table 171. Parenteral Nutrition Medicament Market Challenges
Table 172. Parenteral Nutrition Medicament Market Restraints
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Parenteral Nutrition Medicament
Figure 2. Global Parenteral Nutrition Medicament Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Parenteral Nutrition Medicament Market Share by Type in 2022 & 2029
Figure 4. Heat Product Picture
Figure 5. Amino Acid Product Picture
Figure 6. Vitamins Product Picture
Figure 7. Global Parenteral Nutrition Medicament Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 8. Global Parenteral Nutrition Medicament Market Share by Application in 2022 & 2029
Figure 9. max. 100ml
Figure 10. 250ml
Figure 11. 500ml
Figure 12. min. 1L
Figure 13. Global Parenteral Nutrition Medicament Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Parenteral Nutrition Medicament Market Size (2018-2029) & (US$ Million)
Figure 15. Global Parenteral Nutrition Medicament Sales (2018-2029) & (K Units)
Figure 16. Global Parenteral Nutrition Medicament Average Price (US$/Unit) & (2018-2029)
Figure 17. Parenteral Nutrition Medicament Report Years Considered
Figure 18. Parenteral Nutrition Medicament Sales Share by Manufacturers in 2022
Figure 19. Global Parenteral Nutrition Medicament Revenue Share by Manufacturers in 2022
Figure 20. The Global 5 and 10 Largest Parenteral Nutrition Medicament Players: Market Share by Revenue in 2022
Figure 21. Parenteral Nutrition Medicament Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 22. Global
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs